Open AccessSuccessful management of heterotopic pregnancy after fetal reduction using potassium chloride and methotrexate
Author(s) -
Deepika Deka,
Anupama Bahadur,
Aprajita Singh,
Neena Malhotra
Publication year - 2012
Publication title -
journal of human reproductive sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.484
H-Index - 31
eISSN - 0974-1208
pISSN - 1998-4766
DOI - 10.4103/0974-1208.97807
Subject(s) - heterotopic pregnancy , medicine , pregnancy , gestation , obstetrics , methotrexate , obstetrics and gynaecology , complication , ectopic pregnancy , gynecology , surgery , gestational sac , genetics , biology
Heterotopic pregnancy, the presence of two gestational sacs simultaneously, is a rare event but with the advent of Assisted Reproductive Technology, it is now an increasingly common complication. The reported incidence of a heterotopic pregnancy in a spontaneous cycle is quoted as 1 in 30,000. We report the case of a 38-year-old primigravida who was referred to our center at 11 + 2 weeks gestation with a diagnosis of heterotopic pregnancy for further management. A non-surgical intervention comprising of transvaginal ultrasound-guided potassium chloride and methotrexate into the cervical pregnancy resulted in a successful outcome. As an obstetrician, a high index of clinical suspicion and an early scan is mandatory to make a diagnosis of a heterotopic pregnancy and manage accordingly.